Search results for "Erythromycin"

showing 10 items of 16 documents

Evaluation of antimicrobial resistance and virulence of enterococci from equipment surfaces, raw materials and traditional cheeses

2016

Forty enterococci isolated along the production chains of three traditional cheeses (PDO Pecorino Siciliano, PDO Vastedda della Valle del Belìce, and Caciocavallo Palermitano) made in Sicily (southern Italy) were studied for the assessment of their antibiotic resistance and virulence by a combined phenotypic/genotypic approach. A total of 31 Enterococcus displayed resistance to at least one or more of the antimicrobials tested. The strains exhibited high percentages of resistance to erythromycin (52.5%), ciprofloxacin (35.0%), quinupristin–dalfopristin (20.0%), tetracycline (17.5%), and high-level streptomycin (5.0%). The presence of tet(M), cat(pC221), and aadE genes for resistance to tetr…

0301 basic medicineTetracyclineFood HandlingVirulence Factors030106 microbiologyVirulenceMicrobial Sensitivity TestsAntimicrobial resistanceMicrobiologyMicrobiology03 medical and health sciencesAntibiotic resistanceBacterial ProteinsCheeseDrug Resistance BacterialmedicineAnimal rennetAnimal rennet Antimicrobial resistance Enterococcus Raw milk Traditional cheese Virulence Wooden vatAnimalsHumansGram-Positive Bacterial InfectionsbiologyVirulenceRaw milkTraditional cheeseAnimal rennet Antimicrobial resistance Enterococcus Raw milk Traditional cheese Virulence Wooden vatGeneral MedicineRaw milkbiochemical phenomena metabolism and nutritionbiology.organism_classificationAntimicrobialWooden vatAnti-Bacterial AgentsErythromycinCiprofloxacin030104 developmental biologyMilkEnterococcusEquipment and SuppliesItalyStreptomycinEquipment ContaminationCattleEnterococcusFood Sciencemedicine.drugSettore AGR/16 - Microbiologia Agraria
researchProduct

Effects of Intravenous Erythromycin Lactobionate in Respiratory Infections

1987

The antibiotic erythromycin lactobionate given intravenously acts almost exclusively on Gram-positive bacteria. Even at high plasma and tissue concentrations there is an almost total absence of side-effects. It could be considered, therefore, as first choice in the treatment of patients with infectious respiratory diseases. Most of the 40 patients admitted to the present study were elderly and all had either acute or chronic and becoming acute respiratory disease. Their clinical symptoms and levels of phlogosis improved on treatment with erythromycin lactobionate without any interruption of therapy due to side-effects and toxicity. The absence of unfavourable pharmacological interactions f…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAntibioticsErythromycinBiochemistryGastroenterologyErythromycin LactobionateInternal medicinemedicineHumansInfusions IntravenousRespiratory Tract InfectionsAgedChemotherapyBacteriaRespiratory tract infectionsbusiness.industryBiochemistry (medical)Respiratory diseaseCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseErythromycinSurgeryTolerabilityToxicityFemalebusinessmedicine.drugJournal of International Medical Research
researchProduct

Occurrence of antibiotics in the aquatic environment

1999

The recent monitoring of drug residues in the aquatic environment has gained much interest as many pharmaceutical compounds can frequently be found in sewage treatment plant (STP) effluents and river water at concentrations up to several microgram/l. This article describes the analysis of various water samples for 18 antibiotic substances, from the classes of macrolid antibiotics, sulfonamides, penicillins and tetracyclines. Samples were preconcentrated via lyophilization and quantified using HPLC-electrospray-tandem-mass spectrometry. The investigated STP effluents and surface water samples showed frequent appearance of an erythromycin degradation product, roxithromycin and sulfamethoxazol…

Environmental Engineeringmedicine.drug_classAntibioticsGermanymedicineAnimalsHumansEnvironmental ChemistryWater pollutionWaste Management and DisposalEffluentBacteriaSewageChemistryRoxithromycinSulfamethoxazoleAgricultureDrug Resistance MicrobialContaminationPollutionAnti-Bacterial AgentsErythromycinBiodegradation EnvironmentalEnvironmental chemistrySewage treatmentSurface waterWater Pollutants Chemicalmedicine.drugScience of The Total Environment
researchProduct

Controlled trial for long-term low-dose erythromycin after sinus surgery for chronic rhinosinusitis

2014

Objectives/Hypothesis The efficacy of macrolides in chronic rhinosinusitis (CRS) is still under controversy. To date, only two double-blind, placebo-controlled studies have been published with differing results. None of these studies investigated the possible benefit of macrolides in the postoperative period. We conducted an investigator-initiated clinical trial using 250-mg erythromycin once a day over a period of 3 months, beginning the administration of either erythromycin or placebo 2 weeks after a surgical intervention for CRS. Study Design Randomized double-blind, placebo-controlled trial. Methods The concentrations of eosinophilic cationic protein (ECP) and myeloperoxidase in nasal s…

Eosinophil cationic proteinmedicine.medical_specialtybusiness.industryVisual analogue scaleErythromycinPlacebomedicine.diseaselaw.inventionClinical trialOtorhinolaryngologyRandomized controlled triallawAnesthesiaInternal medicineotorhinolaryngologic diseasesmedicineSecondary Outcome MeasureNasal polypsbusinessmedicine.drugThe Laryngoscope
researchProduct

Induction of Cerebral Ischemic Tolerance by Erythromycin Preconditioning Reprograms the Transcriptional Response to Ischemia and Suppresses Inflammat…

2007

Background A single dose of the macrolide antibiotic erythromycin can induce tolerance against cerebral ischemia in vivo (pharmacologic preconditioning). This study identified potential mechanisms of tolerance induction by assessing effects of erythromycin preconditioning on the cerebral transcriptional response to transient global cerebral ischemia. Methods Preconditioned and nonpreconditioned rats were exposed to 15 min of global cerebral ischemia, and changes in cerebral gene expression were identified by complementary DNA expression array and quantified by real-time reverse-transcription polymerase chain reaction. Results Ischemia caused a widespread up-regulation of transcription in n…

MaleDNA ComplementaryTranscription GeneticIschemiaInflammationPharmacologyNeuroprotectionBrain IschemiaProinflammatory cytokineIn vivoGene expressionmedicineAnimalsRNA MessengerRats WistarIschemic PreconditioningAntibacterial agentInflammationReverse Transcriptase Polymerase Chain Reactionbusiness.industryBrainmedicine.diseaseAnti-Bacterial AgentsErythromycinRatsDisease Models AnimalTolerance inductionAnesthesiology and Pain MedicineAnesthesiamedicine.symptombusinessAnesthesiology
researchProduct

The antibiotic erythromycin induces tolerance against transient global cerebral ischemia in rats (pharmacologic preconditioning).

2006

Background Cerebral ischemic tolerance can be induced by a variety of noxious stimuli, but no clinically applicable regimen for preconditioning has been described. Therefore, the authors tested the ability of a pharmacologic preconditioning strategy using the well-known macrolide antibiotic erythromycin to induce tolerance against transient global cerebral ischemia in vivo. They also investigated whether tolerance induction by erythromycin involves transcriptional and translational changes of cerebral B-cell leukemia/lymphoma-2 (bcl-2) expression. Methods Male Wistar rats were treated with erythromycin (25 mg/kg intramuscularly) or vehicle and subjected to 15 min of transient global cerebr…

MaleIschemiaHippocampusErythromycinPharmacologyNeuroprotectionHippocampusIn vivomedicineAnimalsRNA MessengerRats WistarIschemic PreconditioningAntibacterial agentNeuronsbusiness.industrymedicine.diseaseAnti-Bacterial AgentsErythromycinRatsTolerance inductionAnesthesiology and Pain MedicineProto-Oncogene Proteins c-bcl-2Ischemic Attack TransientImmunologyReperfusionIschemic preconditioningbusinessmedicine.drugAnesthesiology
researchProduct

Clarithromycin Versus Azithromycin in the Treatment of Mediterranean Spotted Fever in Children: A Randomized Controlled Trial

2002

We conducted an open-label randomized controlled trial to compare the efficacy and safety of clarithromycin (15/mg/kg/day in 2 divided doses for 7 days) with those of azithromycin (10 mg/kg/day in 1 dose for 3 days) in the treatment of children with Mediterranean spotted fever. Until now, there has not been a gold-standard therapy for this rickettsial disease in children. Eighty-seven children were randomized to receive 1 of the 2 drugs. The mean time to defervescence (+/- standard deviation) was 46.2+/-36.4 h in the clarithromycin group and 39.3+/-31.3 h in the azithromycin group. These differences were not statistically significant and both drugs were equally well-tolerated. Clarithromyci…

MaleMicrobiology (medical)medicine.medical_specialtyAdolescentErythromycinAzithromycinBoutonneuse FeverAzithromycinDrug Administration Schedulelaw.inventionRandomized controlled triallawClarithromycinClarithromycinInternal medicinemedicineHumansChildAntibacterial agentMediterranean spotted fever Clarithromycin azithromycinbusiness.industryInfantmedicine.diseaseAnti-Bacterial AgentsSurgerySpotted feverBoutonneuse feverRickettsia conoriiTreatment OutcomeInfectious DiseasesRickettsiosisChild PreschoolFemalebusinessmedicine.drugClinical Infectious Diseases
researchProduct

Lack of effect of azithromycin on QT interval in children: a cohort study.

2016

Macrolides are a group of antimicrobial drugs used widely, being well known for their adverse cardiac effects. Erythromycin and clarithromycin are most commonly associated with these conditions. In recent years, azithromycin (AZM) has been assessed because of its possible relation to arrhythmias (mainly QT interval prolongation) and risk of cardiovascular death.1 The pharmacodynamics of these effects is complex and the occurrence of cardiovascular death is unpredictable.2 However, all published manuscripts on the cardiac effects of AZM to date are cases in adults or …

Malemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsRespiratory Tract DiseasesErythromycin030204 cardiovascular system & hematologyAzithromycinAzithromycinQT intervalCardiovascular deathCardiovascular Physiological PhenomenaCohort Studies03 medical and health sciences0302 clinical medicineClarithromycinInternal medicinemedicineHumans030212 general & internal medicineIntensive care medicineChildbusiness.industryAntimicrobialAnti-Bacterial AgentsLong QT SyndromeTreatment OutcomeSpainPharmacodynamicsPediatrics Perinatology and Child HealthChronic DiseaseFemalebusinessElectrophysiologic Techniques Cardiacmedicine.drugCohort studyArchives of disease in childhood
researchProduct

Distribution of emm types among group A streptococcal isolates from Serbia.

2010

AbstractThis is the first study concerning the molecular epidemiology of group A streptococcus in Serbia and includes 145 isolates from patients with various infections during the period 2001–2007. The emm types, superantigen profile and susceptibility pattern were determined. Among 31 emm types identified, the most prevalent were emm6, emm12, emm1, and emm58. All isolates showed uniform antimicrobial susceptibility to all tested antibiotics, with the exception of tetracycline and erythromycin (41% and 0.7% resistant strains, respectively). Significant heterogeneity of emm types was found, with a high frequency of emm6 and emm58, as well as a considerable prevalence of tetracycline resistan…

Microbiology (medical)DNA BacterialMaleGenotypemedicine.drug_classTetracyclineStreptococcus pyogenesErythromycinDrug resistanceMicrobial Sensitivity TestsBiologymedicine.disease_causeMicrobiologyMacrolide Antibioticsresistance03 medical and health sciences0302 clinical medicinestomatognathic systemStreptococcal InfectionsGenotypeotorhinolaryngologic diseasesmedicineHumans030212 general & internal medicine0303 health sciencesAntigens BacterialMolecular EpidemiologyPolymorphism GeneticSuperantigensMolecular epidemiology030306 microbiologyStreptococcusGeneral Medicinebacterial infections and mycosesDNA Fingerprinting3. Good healthAnti-Bacterial Agentsstomatognathic diseasesInfectious Diseasesemm typeStreptococcus pyogenesFemaleCarrier ProteinsSerbiamedicine.drugBacterial Outer Membrane ProteinsClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
researchProduct

Erythromycin:an alternative for the management of oral mucositis?

2022

Oral mucositis (OM) is an important acute adverse effect of anticancer therapy. This condition presents high morbidity and may lead to the suspension of anticancer therapy. We reviewed the literature on the pathobiology of OM and the properties of erythromycin (EM), to consider the possibility of its use for the prevention and treatment of OM. We searched the PubMed, Scopus and Web of Science databases and selected complete articles published in English or Spanish that met the inclusion criteria. The search terms ?erythromycin?, ?inflammation?, ?immunomodulation? and ?oral mucositis? were used. The control of free radicals, transcription factors and pro-inflammatory cytokines has been consi…

MucositisStomatitisdiagnosisgingival hyperplasiaErythromycingingivaOtorhinolaryngologygingival diseasesCytokinesHumansSurgeryoral pathologyGeneral DentistryUNESCO:CIENCIAS MÉDICAS
researchProduct